Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: Refined HLA matching reveals more graft-versus-host disease but not less relapse

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 11, 2009, Pages 1475-1478

  Weisdorf, Daniel J ^a,b   Nelson, Gene ^b   Lee, Stephanie J ^b,c   Haagenson, Michael ^b   Spellman, Stephen ^b   Antin, Joseph H ^d   Bolwell, Brian ^e   Cahn, Jean Yves ^f   Cervantes, Francisco ^g   Copelan, Edward ^e   Gale, Robert ^h   Gratwohl, Alois ⁱ   Khoury, H Jean ^j   McCarthy, Philip ^k   Marks, David I ^l   Szer, Jeff ^m   Woolfrey, Ann ^c   Cortes Franco, Jorge ⁿ   Horowitz, Mary M ^b,o   Arora, Mukta ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY HOSPITAL OF BESANÇON   (France)

^g UNIVERSITY OF BARCELONA   (Spain)

^h Center for Advanced Studies in Leukemia   (United States)

ⁱ UNIVERSITY OF BASEL   (Switzerland)

^j EMORY CLINIC   (United States)

^k ROSWELL PARK CANCER INSTITUTE   (United States)

^l UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^m ROYAL MELBOURNE HOSPITAL   (Australia)

ⁿ UNIVERSITY OF TEXAS   (United States)

^o MEDICAL COLLEGE OF WISCONSIN   (United States)

more..

Author keywords

Chronic myelogenous leukemia; Graft versus leukemia; Graft versus host disease; HLA matching; Unrelated donor allotransplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER RELAPSE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DONOR SELECTION; FEMALE; GRAFT FAILURE; GRAFT VERSUS LEUKEMIA EFFECT; HISTOINCOMPATIBILITY; HLA MATCHING; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; RISK ASSESSMENT; SIBLING; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 70350619476     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.06.016     Document Type: Article

References (8)

1. Weisdorf DJ, Anasetti C, Antin JH, et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood. 2002;99:1971-1977.
2. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110:4576-4583.
3. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplant outcome. Blood. 2004;104:1923-1930.
4. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood. 1998;92:3515-3520.
5. Arora M, Weisdorf DJ, Spellman S, et al. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic-phase chronic myeloid leukemia. J Clin Oncol. 2009;10:1644-1652.
6. Weisdorf D, Spellman S, Haagenson M, et al. Classification of HLA matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant. 2008;14:748-758.
7. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;4: 187-200.
8. Lee SJ, Kukreja M, Wang T, et al. Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. Blood. 2008;112:3500-3507.